{
    "2021-09-16": [
        [
            {
                "time": "2021-02-09",
                "original_text": "Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19",
                "features": {
                    "keywords": [
                        "Emergency Use Authorization",
                        "Lilly",
                        "bamlanivimab",
                        "etesevimab",
                        "post-exposure",
                        "prophylaxis",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-09",
                "original_text": "UPDATE 1-FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus",
                "features": {
                    "keywords": [
                        "FDA",
                        "revises",
                        "Lilly",
                        "COVID-19",
                        "antibody",
                        "combo",
                        "EUA",
                        "exposure",
                        "virus"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-09",
                "original_text": "FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus",
                "features": {
                    "keywords": [
                        "FDA",
                        "revises",
                        "Lilly",
                        "COVID-19",
                        "antibody",
                        "combo",
                        "EUA",
                        "exposure",
                        "virus"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-09",
                "original_text": "Regeneron, Lilly Get New COVID Drug Deals From Government",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Lilly",
                        "New",
                        "COVID",
                        "Drug",
                        "Deals",
                        "Government"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}